Evidence map›Paper›PMID 39511647›Full record

ArticleVirology journal2024

Characterization of phage HZY2308 against Acinetobacter baumannii and identification of phage-resistant bacteria.

Ruilin Wang, Xiaojuan You, Xinwei Liu, Bing Fei, Yifan Li, Dan Wang, Rui Zhu, Yongwei Li

Abstract read
In one paragraph

Article in Virology journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Phage Therapy forAntibiotics (Basel, Switzerland) · 2025
    Review
  19. Article
  20. Carbapenem Resistance inMicroorganisms · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ruilin Wang *The Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, 450002, China.
Xiaojuan You *The Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, 450002, China.
Xinwei LiuThe Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, 450002, China.
Bing FeiThe Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, 450002, China.
Yifan LiThe Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, 450002, China.
Dan WangThe Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, 450002, China.
Rui ZhuThe Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, 450002, China. zr4487933891@163.com.
Yongwei LiThe Second Clinical Medical College of Henan University of Chinese Medicine, Zhengzhou, 450002, China. lyw@hactcm.edu.cn.

Funding

Henan Provincial Science and Technology Research Project No. 232102310153Henan University of Chinese Medicine 2023 annual postgraduate research and innovation ability improvement plan project 2023KYCX050he Natural Science Foundation of Henan Province No.242300420437the Key Scientific Research project of Henan Higher Education Institutions No.24A310007Wu Jieping Medical Foundation 320.6750.2024-03-27
6 · The paper itself

Abstract

backgroundAcinetobacter baumannii (AB) is a notable cause of hospital-acquired infections, with carbapenem-resistant Acinetobacter baumannii (CRAB) classified as a high-priority critical pathogen. Bacteriophage therapy is emerging as a promising alternative to combat drug-resistant bacterial infections. In this study, a lytic phage, HZY2308, was isolated from hospital sewage, and the biological properties, biosafety and anti-biofilm properties of phage HZY2308 were characterized and identified. Moreover, the antibacterial effect of phage HZY2308 in combination with antibiotics was investigated, and the apparent characteristics of phage-resistant strain AB48-R were demonstrated, which provided data support for further studies to elucidate the mechanism of generating phage resistance.

methodsPhage HZY2308 was isolated by double agar plate method using clinical strain AB48 as the host bacterium. The morphology of phage HZY2308 was identified by transmission electron microscopy (TEM), and biological characteristics of phage HZY2308 were identified by host range, the efficiency of plating (EOP), sensitivity to temperature, pH, and chloroform, one-step growth curve, the optimal multiplicity of infection (MOI), and detection of endotoxin and cytotoxicity. Besides, the complete genome map of HZY2308 was constructed using CGview, and the phylogenetic tree of HZY2308 was constructed with MEGA. Additionally, the full genomic sequence of phage HZY2308 and the selected phage were compared using Easyfig. Checkerboard test of phage HZY2308 in combination with tigecycline (TGC) was performed to investigate their synergistic effect and bactericidal kinetics. The effect of HZY2308 on biofilm was investigated by semi-quantitative staining of biofilm with crystal violet, determination of bacterial activity in biofilm by 2,3-Bis (2-methoxy-4-nitro-5-sulfophenyl) -2 H-tetrazolium-5-carboxanilide (XTT) assay and observation of biofilm structure by fluorescence microscopy. Finally, Phage-resistant bacteria AB48-R were characterized by colony-forming capacity, morphology, growth curves, adsorption efficiency, and antibiotic susceptibility assays.

resultsA lytic phage, HZY2308, was isolated from hospital sewage, which exhibited advantageous traits such as a brief incubation period, large burst size, and robust stability. Safety assessments conducted at both genetic and cellular levels also have yielded positive outcomes. Besides, phage HZY2308 effectively inhibited AB biofilm formation and disrupted established biofilm structures. Furthermore, a synergistic antibacterial effect was noted when phage HZY2308 was combined with tigecycline. Interestingly, the phage-resistant strain, AB48-R was screened through natural selection. Compared to the wild strain AB48, the adsorption efficiency of the phage to AB48-R diminished. However, AB48-R's sensitivity to antibiotics such as cefepime, gentamicin, amikacin, and tobramycin increased, indicating an evolutionary trade-off.

conclusionsPhage HZY2308 shows strong antimicrobial potential, especially in combination with tigecycline, and the phage-resistant strain exhibits increased antibiotic sensitivity.

Indexed as

Acinetobacter baumanniiAnti-Bacterial AgentsBacteriophagesBiofilmsHost SpecificityAcinetobacter InfectionsGenome, ViralHumansPhage TherapyPhylogenySewageAnti-Bacterial AgentsSewageAcinetobacter baumanniiBiofilmLytic phagePhage resistance

Identifiers

PMID39511647
PMCPMC11546264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.